N-乙基 -甲基-全氟酸 3-[(1S)-1-(二甲基氨基)乙基] 苯酯酒石酸酯

产品名称：

129101-54-8
Rivastigmine Hydrogen Tartrate
ENA-713
S-Rivastigmine tartrate
Rivastigmine tartrate
N-Ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester tartrate
Ethylmethyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
重酒石酸卡巴拉汀
卡巴拉汀酒石酸酯
N-乙基 -甲基-全氟酸 3-[(1S)-1-(二甲基氨基)乙基] 苯酯酒石酸酯
酒石酸卡巴拉汀酒石酸酯
乙基甲基氨基甲酸 3-[(1S)-1-(二甲基氨基)乙基]苯基酯

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

卡巴拉汀是一种口服口服、脑透过性、可逆的胆碱酯酶抑制剂，可增强阿尔茨海默症和帕金森氏病患者的认知功能。卡巴拉汀可同时抑制丁酰胆碱酯酶和乙酰胆碱酯酶。

包装

Unit quantity: 350 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₄H₂₂N₂O₂· C₄H₆O₆
分子量	400.42
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
储存温度	2-8℃
InChI	1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1
InChI key	GWHQHAUAXRMMOT-RWALOXMOSA-N

安全信息

象形图
警示用语：	Danger
危险声明	H300 - H411
预防措施声明	P264 - P270 - P273 - P301 + P310 - P391 - P405
危险分类	Acute Tox. 2 Oral - Aquatic Chronic 2
储存分类代码	6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable